FI963461A - Häiriönpoistoaineet immunologisia määrityksiä varten - Google Patents

Häiriönpoistoaineet immunologisia määrityksiä varten Download PDF

Info

Publication number
FI963461A
FI963461A FI963461A FI963461A FI963461A FI 963461 A FI963461 A FI 963461A FI 963461 A FI963461 A FI 963461A FI 963461 A FI963461 A FI 963461A FI 963461 A FI963461 A FI 963461A
Authority
FI
Finland
Prior art keywords
disruptors
immunoassays
Prior art date
Application number
FI963461A
Other languages
English (en)
Swedish (sv)
Other versions
FI963461A0 (fi
FI114341B (fi
Inventor
Rosemarie Kientsch-Engel
Frederic Donie
Michael Wiedmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4407423A external-priority patent/DE4407423A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI963461A0 publication Critical patent/FI963461A0/fi
Publication of FI963461A publication Critical patent/FI963461A/fi
Application granted granted Critical
Publication of FI114341B publication Critical patent/FI114341B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI963461A 1994-03-05 1996-09-04 Avidiinin tai streptavidiinin käyttö häiriönpoistoaineena immunologisissa määrityksissä ja määritysmenetelmät, joissa käytetään tätä ainetta FI114341B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4407423 1994-03-05
DE4407423A DE4407423A1 (de) 1994-03-05 1994-03-05 Entstörmittel zum Einsatz bei Immunoassays
PCT/EP1995/000690 WO1995023800A1 (de) 1994-03-05 1995-02-25 Photoaktivierbare biotinderivate und deren einsatz zum entstören von immunoassays
EP9500690 1995-02-25
PCT/EP1995/000776 WO1995023801A1 (de) 1994-03-05 1995-03-03 Entstörmittel zum einsatz bei immunoassays
EP9500776 1995-03-03

Publications (3)

Publication Number Publication Date
FI963461A0 FI963461A0 (fi) 1996-09-04
FI963461A true FI963461A (fi) 1996-09-04
FI114341B FI114341B (fi) 2004-09-30

Family

ID=25934426

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963461A FI114341B (fi) 1994-03-05 1996-09-04 Avidiinin tai streptavidiinin käyttö häiriönpoistoaineena immunologisissa määrityksissä ja määritysmenetelmät, joissa käytetään tätä ainetta

Country Status (5)

Country Link
US (1) US5863740A (fi)
JP (1) JP3027770B2 (fi)
CA (1) CA2184386C (fi)
FI (1) FI114341B (fi)
WO (1) WO1995023801A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4434093A1 (de) * 1994-09-23 1996-03-28 Boehringer Mannheim Gmbh Verfahren zum qualitativen oder/und quantitativen Nachweis einer zu bestimmenden Substanz
IL114149A0 (en) * 1995-06-14 1995-10-31 Yeda Res & Dev Modified avidin and streptavidin molecules and use thereof
FI100276B (fi) * 1996-02-06 1997-10-31 Orion Yhtymae Oy Menetelmä analyyttien ei-kilpailevaa määritystä varten
DE19724787A1 (de) * 1997-06-06 1998-12-10 Biotez Berlin Buch Gmbh Bioche Streptavidin/Avidin beschichtete Oberflächen
ATE225511T1 (de) * 1997-12-11 2002-10-15 Roche Diagnostics Gmbh Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
US6410692B2 (en) * 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
ES2180241T3 (es) * 1998-05-06 2003-02-01 Roche Diagnostics Gmbh Eliminacion de interferencias causadas por factores reumaticos.
US6670194B1 (en) * 1998-08-25 2003-12-30 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US6143507A (en) * 1998-10-29 2000-11-07 Boehringer Ingelheim Pharmaceuticals, Inc. High throughput compatible assay for receptor-TRAF interactions
US6629040B1 (en) 1999-03-19 2003-09-30 University Of Washington Isotope distribution encoded tags for protein identification
AU2001266894B2 (en) 2000-06-12 2006-03-16 University Of Washington Selective labeling and isolation of phosphopeptides and applications to proteomeanalysis
US7223368B2 (en) * 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7223534B2 (en) * 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7771922B2 (en) * 2002-05-03 2010-08-10 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic device
US7214530B2 (en) * 2002-05-03 2007-05-08 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
US7485453B2 (en) * 2002-05-03 2009-02-03 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7118855B2 (en) * 2002-05-03 2006-10-10 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7091049B2 (en) * 2002-06-26 2006-08-15 Kimberly-Clark Worldwide, Inc. Enhanced diffraction-based biosensor devices
US7169550B2 (en) * 2002-09-26 2007-01-30 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US20050112586A1 (en) * 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
US20060114172A1 (en) * 2004-11-26 2006-06-01 Giotti, Inc. Method and apparatus for LED based modular display
US8445293B2 (en) * 2005-02-09 2013-05-21 Rapid Pathogen Screening, Inc. Method to increase specificity and/or accuracy of lateral flow immunoassays
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US20110086359A1 (en) 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
KR101988600B1 (ko) 2011-06-29 2019-06-12 가부시키가이샤 엘에스아이 메디엔스 비특이 반응 억제제, 비특이 반응 억제 방법 및 키트
US20140242620A1 (en) * 2011-08-01 2014-08-28 Japan Tobacco Inc. Method of inhibiting non-specific binding in step of detecting substance in biological sample, and agent for use in the method
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
EP3857227B1 (en) * 2018-09-25 2023-10-25 Siemens Healthcare Diagnostics Inc. Composition for removing hapten interference from assays
EP3857226B1 (en) * 2018-09-25 2023-11-15 Siemens Healthcare Diagnostics Inc. Methods and compositions for removing biotin interference from assays using conjugated molecular traps
CN112129955B (zh) * 2019-06-25 2023-04-07 迈克生物股份有限公司 睾酮检测试剂盒
CN112129933B (zh) * 2019-06-25 2024-01-05 迈克生物股份有限公司 一种免疫分析系统中抗生物素干扰的试剂、试剂盒及方法
EP4290235A1 (de) * 2022-06-10 2023-12-13 Siemens Healthcare Diagnostics Products GmbH Verfahren zur neutralisation einer biotininterferenz in bindungstesten

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314523D0 (en) * 1983-05-25 1983-06-29 Lowe C R Diagnostic device
EP0155854B1 (en) * 1984-03-22 1990-09-26 Bresatec Limited Non-radioactive biological probes
JP2624470B2 (ja) * 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
DE3800644A1 (de) * 1988-01-12 1989-07-20 Boehringer Mannheim Gmbh Verfahren zum hochspezifischen nachweis von nukleinsaeuren in loesung
US5268306A (en) * 1988-02-29 1993-12-07 Boehringer Mannheim Gmbh Preparation of a solid phase matrix containing a bound specific binding pair
US4914040A (en) * 1988-03-03 1990-04-03 Boehringer Mannheim Gmbh Reagent and method for determination of a polyvalent substance using an immunoaggregate
DE3915135A1 (de) * 1989-05-09 1990-11-15 Boehringer Mannheim Gmbh Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten
US5252466A (en) * 1989-05-19 1993-10-12 Biotechnology Research And Development Corporation Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
DE4040669A1 (de) * 1990-12-19 1992-06-25 Behringwerke Ag Verwendung von peptidpaaren mit extrem hoher spezifischer affinitaet zueinander im bereich der in vitro diagnostik
US5528338A (en) * 1991-06-17 1996-06-18 Seiko Epson Corporation Thermal development device
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE4135543A1 (de) * 1991-10-28 1993-04-29 Boehringer Mannheim Gmbh Rekombinantes core-streptavidin
US5260004A (en) * 1991-12-02 1993-11-09 The United States Of America As Represented By The Secretary Of The Army Process of making Langmuir-Blodgett films having photo-electronic properties
US5487975A (en) * 1993-11-15 1996-01-30 Ventana Medical Systems, Inc. Biotin/avidin formulation

Also Published As

Publication number Publication date
WO1995023801A1 (de) 1995-09-08
JPH09510289A (ja) 1997-10-14
FI963461A0 (fi) 1996-09-04
CA2184386A1 (en) 1995-09-08
FI114341B (fi) 2004-09-30
US5863740A (en) 1999-01-26
JP3027770B2 (ja) 2000-04-04
CA2184386C (en) 2005-10-18

Similar Documents

Publication Publication Date Title
FI963461A (fi) Häiriönpoistoaineet immunologisia määrityksiä varten
NO955167D0 (no) Monoklonalt anti-
DE69532542D1 (de) Einpressmutter
DE69524185D1 (de) Zwei-walzen-giessverfahren
FI955927A (fi) Substituoidut 1H-imidatsolit
DE69524726T2 (de) Strahlbohrbrenner
DE69534718D1 (de) Substituierte 9-alkyladenine
DE69505070T2 (de) Laseroszillator
DE69512585T2 (de) Faltblenden
DE69507562T2 (de) Kopiergerät
DE59507277D1 (de) Falzapparat
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
DE59510274D1 (de) Substituierte biphenyloxazoline
DE69524980D1 (de) Bildsynthetisierungsgerät
DE9405034U1 (de) Ohrmutter
KR960010058U (ko) 미끄럼틀
DE29521724U1 (de) Schnellhefter
DE9404605U1 (de) Ordner
KR950032563U (ko) 바인더
KR960020771U (ko) 바인더
KR950032564U (ko) 바인더
KR950029842U (ko) 바인더
KR950032562U (ko) 바인더
KR950027027U (ko) 앨범용 내지
KR960019939U (ko) 제기

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ROCHE DIAGNOSTICS INC.

FG Patent granted

Ref document number: 114341

Country of ref document: FI

MA Patent expired